Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C3 anticorps (HRP)

L’anticorps Mouton Polyclonal anti-C3 a été validé pour WB et EIA. Il convient pour détecter C3 dans des échantillons de Humain.
N° du produit ABIN113306

Aperçu rapide pour C3 anticorps (HRP) (ABIN113306)

Antigène

Voir toutes C3 Anticorps
C3 (Complement Component 3 (C3))

Reactivité

  • 107
  • 54
  • 36
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
Humain

Hôte

  • 79
  • 44
  • 37
  • 8
  • 6
  • 5
  • 1
Mouton

Clonalité

  • 131
  • 48
Polyclonal

Conjugué

  • 83
  • 24
  • 23
  • 11
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp C3 est conjugé à/à la HRP

Application

  • 112
  • 51
  • 44
  • 38
  • 37
  • 32
  • 31
  • 30
  • 28
  • 23
  • 22
  • 13
  • 13
  • 8
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Specificité

    This antibody detects Complement 3c, a polypeptide fragment which is present in C3.

    Purification

    Affinity chromatography on Protein G.

    Immunogène

    Complement 3c.
  • Indications d'application

    Suitable for ELISA (1/200-1/800) and Western blotting (1/500-1/2000).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1.0 mg/mL

    Buffer

    PBS, pH 7.2, containing 0.01 % Thiomersal as preservative.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store lyophilized product at 2 - 8 °C. Following reconstitution store at -20 °C.
  • Antigène

    C3 (Complement Component 3 (C3))

    Autre désignation

    Complement C3

    Sujet

    C3 plays a central role in the activation of the complement system. Processing of C3 by C3 convertase is the central reaction in both classical and alternative complement pathways, resulting in C3a and C3b. C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates, and help to initiate the complement cascade, potentially resulting in cellular apoptosis. C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. C3b is rapidly split in two positions by factor I and a cofactor to form iC3b (inactivated C3b) and C3f which is released. Then iC3b is slowly cleaved (possibly by factor I) to form C3c and C3dg. Defects in C3 can result in susceptibility to pyogenic infection.Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, CPAMD1, Complement component 3

    ID gène

    718

    NCBI Accession

    NP_000055

    UniProt

    P01024

    Pathways

    Système du Complément, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Vous êtes ici:
Chat with us!